In this episode of TDR Cannabis in Five, presented by Dutchie, host Shadd Dales looks at what could happen if cannabis is officially rescheduled at the federal level.
Rescheduling would mark a significant shift, moving cannabis from Schedule I to Schedule III or beyond. This change would open new pathways for medical research, academic partnerships, and corporate involvement. Universities such as Johns Hopkins, Harvard Medical School, and UCLA could run federally supported studies, while hospitals like MD Anderson and the Cleveland Clinic would be able to launch clinical trials on chronic pain, cancer care, and neurological conditions. For the first time, real data would flow into the FDA.
Cannabis companies would also play a role. Multi-state operators like Curaleaf, Green Thumb Industries, and Trulieve could partner with universities, while Canadian firms such as Tilray and Aurora may expand their medical collaborations into the U.S. Research would range from pharmaceutical trials to product safety studies, agricultural development, and public health analysis.
Rescheduling also sets the stage for broader corporate involvement. Big Tobacco companies like Altria and Philip Morris, Big Alcohol players such as Constellation Brands, Molson Coors, and AB InBev, and even Big Pharma leaders could expand into the sector through partnerships or acquisitions.
The pace of change could be rapid: universities applying for grants within weeks, clinical trials within a year, and FDA-approved cannabinoid medicines within a few years. This episode outlines the potential infrastructure, partnerships, and timelines that could follow rescheduling.
#CannabisNews #TDRCannabis #CannabisRescheduling #CannabisResearch #CannabisPolicy #CannabisLegalization #Dutchie #AdultUseCannabis #CannabisIndustry #CannabisReform
Want to see last week’s recap?
https://youtu.be/3EC_dJwboZU
Want to see more Cannabis Reform videos?
https://youtu.be/8jmQqJIWtZs
https://youtu.be/gQn5Ye-BlkM
https://youtu.be/woaTa3UYRcU
https://youtu.be/Ux_NyevgB9k
https://youtu.be/l4oDM6Hj7dc
Want to be updated on Cannabis, Small Cap, AI, and Crypto? Subscribe to our Daily Baked in Newsletter!
https://newsletter.thedalesreport.com/subscribe
Find us as well on Facebook, Twitter, Instagram, LinkedIn and on the Web:
Facebook: https://www.facebook.com/TheDalesReport
Twitter: https://twitter.com/TheDalesReport
Instagram: https://www.instagram.com/dalesreport
LinkedIn: https://www.linkedin.com/company/the-dales-report/
Apple Podcasts: https://tinyurl.com/TDRTradetoBlackonApplePodcasts
Spotify: https://tinyurl.com/TDRTradeToBlackonSpotify
Website: https://thedalesreport.com/
For copyright matters, please get in touch with us at:
[email protected]
All views on the Trade To Black podcast and the guests on this podcast are purely opinions. You should not treat any opinions expressed by us or our guests as investment advice. The views on this podcast are solely intended to be informational and are not investment advice. Please go to our website for a full list of disclosures and details of any client relationship we have.
https://thedalesreport.com/website-terms-of-use/
